Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Controlled trials of inositol in psychiatry
A common question is whether to administer GLP-1 injections in the morning or at night
Our companion paper, Evaluating Biometric Trend Drivers: How to reflect medical breakthroughs and other drivers in forward-looking assumptions, explores the practicalities for insurers in maintaining an up-to-date view on emerging biometric trend drivers such as AOMs and provides a framework for incorporating the insured mortality impacts into insured improvement bases
Despite these numbers, GLP-1 drugs account for relatively small shares of total Medicaid spending and prescriptions, the report noted -- about 0.5% of all Medicaid prescriptions and 3.7% of gross Medicaid spending
video analytics, path optimization via cuOpt, etc
Mohamed-Noriega K, Loya-Garcia D, Vera-Duarte GR, et al
US$ 23.32
US$ 27.27
US$ 24.17
US$ 27.37
US$ 28.52
US$ 27.37
